O-GlcNAcylation of UGDH: emerging insights into immunometabolic regulation and therapeutic implications

Lin B, Zhou J, Geng D, Chai S, Zhang X, Zhang Z, et al. O-GlcNAcylation of UGDH regulates its activity and remodels the extracellular matrix to facilitate tumor growth. Cell Death Differ. 2025. https://doi.org/10.1038/s41418-025-01591-8 . Google Scholar Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, et al. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA. 2023;120:e2216796120. https://doi.org/10.1073/pnas.2216796120 . Google Scholar Zhan D, Yalcin F, Ma D, Fu Y, Wei S, Lal B, et al. Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth. Genes Dis. 2022;9:717–30. https://doi.org/10.1016/j.gendis.2021.08.008 . Google Scholar Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, et al. KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell. 2019;35:559–72.e557. https://doi.org/10.1016/j.ccell.2019.02.008 . Google Scholar Martinez-Ordoñez A, Duran A, Ruiz-Martinez M, Cid-Diaz T, Zhang X, Han Q, et al. Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer Cell. 2023;41:252–71.e259. https://doi.org/10.1016/j.ccell.2022.11.016 . Google Scholar Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017–22. https://doi.org/10.1038/nature05815 . Google Scholar Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014;54:820–31. https://doi.org/10.1016/j.molcel.2014.04.026 . Google Scholar Cheng SS, Mody AC, Woo CM. Opportunities for therapeutic modulation of O-GlcNAc. Chem Rev. 2024;124:12918–3019. https://doi.org/10.1021/acs.chemrev.4c00417 . Google Scholar Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbæk MS, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7:68 https://doi.org/10.1186/s40425-019-0556-6 . Google Scholar Yin H, Zhu J. Methods for quantification of glycopeptides by liquid separation and mass spectrometry. Mass Spectrom Rev. 2023;42:887–917. https://doi.org/10.1002/mas.21771 . Google Scholar Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough JS, Nguyen H, Cuevas C, et al. T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma. Cancer Cell. 2015;28:638–52. https://doi.org/10.1016/j.ccell.2015.09.022 . Google Scholar Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, et al. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell. 2019;35:885–900. https://doi.org/10.1016/j.ccell.2019.05.004 . Google Scholar Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18:452–65. https://doi.org/10.1038/nrm.2017.22 . Google Scholar Sun K, Zhi Y, Ren W, Li S, Zheng J, Gao L, et al. Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance. Exp Hematol Oncol. 2024;13:107 https://doi.org/10.1186/s40164-024-00569-5 . Google Scholar Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV, et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol. 2012;30:858–67. https://doi.org/10.1038/nbt.2317 . Google Scholar Download references